Paper
RSC Advances
1
,3-Dipicolyl hexahydropyrimidine (1a). Yellow oil (3.50 g, white powder from CH
2
Cl
2
/diethyl ether produced the pure
1
8
(
7%, based on the starting pyridine-2-formaldehyde). H NMR products.
400 MHz, CDCl ): d 8.37–8.35 (m, 2H, Py–H), 7.48–7.44 (m, 2H,
1,3-Dipicolyl
Py–H), 7.32 (d, J ¼ 7.6 Hz, 2H, Py–H), 6.99–6.96 (m, 2H, Py–H), phosphate (3a). Colorless crystal (0.78 g, 95%). Mp: 107–
tetrahydropyrimidin-1-ium
hexauoro-
3
ꢀ
1
3
(
.60 (s, 4H, picolyl–CH
2 2
), 3.19 (s, 2H, pyrimidine–CH
6
), 2.51 108 C. H NMR (400 MHz, DMSO-d ): d 8.84 (s, 1H, pyrimidine–
1
3
s, 4H, pyrimidine–CH ), 1.61 (s, 2H, pyrimidine–CH ) ppm.
C
CH), 8.63 (d, J ¼ 4.2 Hz, 2H, Py–H), 7.93–7.89 (m, 2H, Py–H),
2
2
NMR (100 MHz, CDCl ): d 158.7, 148.8, 136.2, 122.8, 121.8, 75.2, 7.52 (d, J ¼ 7.8 Hz, 2H, Py–H), 7.44–7.41 (m, 2H, Py–H), 4.85 (s,
3
+
6
0.7, 52.2, 22.6 ppm. ESI-MS (m/z): 269.0 [M + H] .
4H, picolyl–CH
2
), 3.37–3.32 (m, 4H, pyrimidine–CH
2
), 2.02–1.95
): d
oil (3.96 g, 89%, based on the starting pyridine- 155.6, 154.3, 150.1, 137.9, 124.0, 123.1, 59.0, 43.5, 18.8 ppm.
1
3
5
2 6
,5-Dimethyl-1,3-dipicolyl hexahydropyrimidine (1b). Yellow (m, 2H, pyrimidine–CH ) ppm. C NMR (100 MHz, DMSO-d
1
+
2
(
3
(
-formaldehyde). H NMR (400 MHz, CDCl
m, 2H, Py–H), 7.50–7.40 (m, 4H, Py–H), 6.99–6.95 (m, 2H, Py–H),
.51 (s, 4H, picolyl–CH ), 3.06 (bs, 2H, pyrimidine–CH
), 2.03 uorophosphate (3b). Colorless crystal (0.83 g, 94%). Mp:
bs, 4H, pyrimidine–CH ), 0.87 (s, 6H, CH ) ppm. C NMR (100 109 C. H NMR (400 MHz, DMSO-d
3
): d 8.35–8.34 ESI-MS (m/z): 267.2 [M ꢁ PF
6
] .
5,5-Dimethyl-1,3-dipicolyl tetrahydropyrimidin-1-ium hexa-
2
2
1
3
ꢀ
1
6
): d 8.94 (s, 1H, pyrimidine–
2
3
MHz, CDCl ): d 158.9, 148.7, 136.3, 122.5, 121.8, 76.7, 64.6, 61.5, CH), 8.64 (d, J ¼ 4.2 Hz, 2H, Py–H), 7.93–7.89 (m, 2H, Py–H),
3
+
+
3
1.2, 25.9 ppm. ESI-MS (m/z): 297.1 [M + H] , 319.2 [M + Na] .
7.54 (d, J ¼ 7.7 Hz, 2H, Py–H), 7.44–7.41 (m, 2H, Py–H), 4.84 (s,
H, picolyl–CH ), 3.07 (s, 4H, pyrimidine–CH ), 0.82 (s, 6H,
CH ) ppm. C NMR (100 MHz, DMSO-d ): d 154.5, 154.0, 150.1,
4
2
2
1
3
3
6
Synthesis of 1,3-dipicolyl tetrahydropyrimidin-1-ium
bromides (2a–b)
1
2
37.9, 124.1, 123.6, 58.9, 54.0, 27.2, 23.7 ppm. ESI-MS (m/z):
+
95.1 [M ꢁ PF ] .
6
Hexahydropyrimidine (1a or 1b, 5 mmol) was dissolved in DME
(
20 mL). NBS (5 mmol, 0.89 g) was added portion-wise and the
Synthesis of 1,3-dipicolyl-3,4,5,6-tetrahydropyrimidin-
-ylidenes palladium complexes (4a–b)
A mixture of tetrahydropyrimidin-1-ium hexauorophosphate
resulting mixture was stirred at room temperature for 3 h,
during which time a white precipitate formed. The precipitate
was ltered and washed with DME. Crystallization of the
precipitate from CH Cl /diethyl ether produced the pure
products.
,3-Dipicolyl tetrahydropyrimidin-1-ium bromides (2a).
2
(
(
3a or 3b, 2.0 mmol), PdCl (2.0 mmol, 0.35 g) and NaN(SiMe )
2 3 2
1.2 mL, 2.0 M in THF) in pyridine (6 mL) was heated at 140 C
2
2
ꢀ
for 12 h. The reaction mixture was then evaporated and puri-
cation of the residue by column chromatography (silica,
1
ꢀ
1
Colorless crystal (1.40 g, 81%). Mp: 158–159 C. H NMR
400 MHz, DMSO-d
CHCl
palladium complexes.
1,3-Dipicolyl-3,4,5,6-tetrahydropyrimidin-2-ylidenes) PdCl$PF6
3
/diethyl ether, gradient elution) produced the pure
(
6
): d 8.91 (s, 1H, pyrimidine–CH), 8.63 (d, J ¼
.8 Hz, 2H, Py–H), 7.93–7.89 (m, 2H, Py–H), 7.52 (d, J ¼ 7.7 Hz,
H, Py–H), 7.44–7.41 (m, 2H, Py–H), 4.85 (s, 4H, picolyl–CH ),
.33 (t, J ¼ 5.8 Hz, 4H, pyrimidine–CH ), 1.96 (t, J ¼ 5.6 Hz, 2H,
4
2
3
(
2
1
(
4a). Colorless crystal (0.64 g, 58%). H NMR (400 MHz, DMSO-
2
d6): d 9.00–8.98 (m, 2H, Py–H), 8.22–8.18 (m, 2H, Py–H), 7.88 (d,
J ¼ 7.1 Hz, 2H, Py–H), 7.67–7.63 (m, 2H, Py–H), 5.30 (d, J ¼ 15.1
1
3
pyrimidine–CH ) ppm. C NMR (100 MHz, CDCl ): d 154.9,
1
2
3
53.0, 149.4, 137.2, 123.4, 123.2, 58.8, 53.7, 43.1, 18.7 ppm. ESI-
Hz, 2H, picolyl–CH
2
), 4.80 (d, J ¼ 15.3 Hz, 2H, picolyl–CH
2
),
+
MS (m/z): 267.1 [M ꢁ Br] .
,5-Dimethyl-1,3-dipicolyl
bromides (2b). Colorless crystal (1.45 g, 77%). Mp: 239 C. H
NMR (400 MHz, DMSO-d ): d 9.07 (s, 1H, pyrimidine–CH), 8.63
t, J ¼ 2.4 Hz, 2H, Py–H), 7.93–7.89 (m, 2H, Py–H), 7.57 (d, J ¼ 7.8
Hz, 2H, Py–H), 7.44–7.41 (m, 2H, Py–H), 4.86 (s, 4H, picolyl–
3.58–3.48 (m, 4H, pyrimidine–CH
2
), 1.92 (t, J ¼ 5.8 Hz, 2H,
5
tetrahydropyrimidin-1-ium
1
3
pyrimidine–CH
2
) ppm. C NMR (100 MHz, DMSO-d ): d 174.9,
6
ꢀ
1
154.8, 154.0, 141.4, 125.6, 125.2, 61.6, 47.5, 20.8 ppm. Anal.
6
cacld for C H ClF N PPd (551.99): C, 34.74; H, 3.28; N, 10.13.
1
6
18
6 4
(
Found: C, 34.56; H, 3.02; N, 9.89%.
5,5-Dimethyl-1,3-dipicolyl-3,4,5,6-tetrahydropyrimidin-2-yli-
(
1
3
CH ), 3.07 (s, 4H, pyrimidine–CH ), 0.82 (s, 6H, CH ) ppm.
NMR (100 MHz, DMSO-d ): d 154.5, 154.1, 150.1, 137.9, 124.1,
1
C
2
2
3
1
denes)PdCl$PF
6
(4b). Light yellow solid (0.70 g, 60%). H NMR
400 MHz, DMSO-d
): d 9.01 (d, J ¼ 4.9 Hz, 2H, Py–H), 8.23–8.19
m, 2H, Py–H), 7.86 (d, J ¼ 7.4 Hz, 2H, Py–H), 7.68–7.65 (m, 2H,
), 4.77 (d, J ¼ 15.2
), 3.28 (d, J ¼ 3.2 Hz, 4H, pyrimidine–CH ),
.79 (s, 6H, CH ) ppm. C NMR (100 MHz, DMSO-d ): d 174.0,
6
(
(
6
+
23.6, 58.9, 54.0, 27.2, 23.7 ppm. ESI-MS (m/z): 295.1 [M ꢁ Br] .
Py–H), 5.38 (d, J ¼ 15.1 Hz, 2H, picolyl–CH
2
Hz, 2H, picolyl–CH
2
2
Synthesis of 1,3-dipicolyl tetrahydropyrimidin-1-ium
hexauorophosphates (3a–b)
1
3
0
1
3
6
54.9, 154.0, 141.5, 125.5, 125.2, 61.6, 58.7, 28.1, 23.5 ppm.
4 6
NH PF (3 mmol, 0.49 g) was dissolved in water (5 mL). The
water solution was then combined with an ethanol (25 mL)
solution of tetrahydropyrimidin-1-ium bromides (2a or 2b,
Anal. cacld for C H ClF N PPd (580.02): C, 37.20; H, 3.82; N,
1
8
22
6 4
9.64. Found: C, 36.93; H, 3.87; N, 9.49%.
2
mmol) and the mixture was then stirred at room temperature
for 5 h. The solvent was then evaporated and the residue was
poured into a mixture of water (10 mL) and CH Cl (10 mL). The The Heck reaction was conducted in a parallel reactor. In a
General procedure for the Heck reaction
2
2
resulting solution was then extracted by CH Cl (10 mL) for typical reaction, A Schlenk tube was charged with aryl bromides
2
2
3
times. The combined organic phase was then washed by (0.5 mmol), acrylate or styrene (0.75 mmol), base (0.75 mmol),
water, dried and evaporated. Crystallization of the resulting pincer NHC–Pd complex 4a or 4b, and solvent (2 mL). The
This journal is © The Royal Society of Chemistry 2015
RSC Adv., 2015, 5, 25723–25729 | 25727